Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 3682 3792 3796
This examiner grants 83% of resolved cases
Joshua Brendon Solomon is an examiner in Tech Center 3700 and Art Unit 3682. The examiner has resolved 308 cases and holds an allowance rate of 83.4 percent. This 83.4 percent rate provides a baseline for the probability of success for applications. The median days to allowance is 924, outlining the timeframe for the 308 cases that have reached issuance. This 924-day period is a factor for applicants to consider when planning their prosecution strategy.
The interview lift is 20.3 percent, indicating that interviews are an effective way to increase the likelihood of a grant. This 20.3 percent lift is an increase over the 83.4 percent baseline allowance rate. Practitioners should consider the 924-day median pendency and the positive impact of interviews when planning their prosecution strategy. The data suggests that direct engagement can enhance the 83.4 percent probability of success.
With 308 cases resolved, the 83.4 percent allowance rate and 20.3 percent interview lift are reliable metrics. The 924-day median timeline to allowance is a key factor for managing expectations. These figures suggest that direct engagement through interviews can improve the 83.4 percent chance of success in Art Unit 3682 and help in refining the approach to the prosecution process.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18660623 | INTRAVENOUS POLE FOR IMPROVED SAFETY AND ACCURACY OF INTRAVENOUS MEDICATION ADMINISTRATION | Final Rejection | University of Massachusetts |
| 18910891 | GENERATING PATIENT STATES BASED ON PATIENT GOALS | Final Rejection | Boston Scientific Neuromodulation Corporation |
| 17932928 | Using Evoked Potentials for Brain Stimulation Therapies | Non-Final OA | Boston Scientific Neuromodulation Corporation |
| 18564391 | SYSTEMS AND METHODS OF USING NANOMEMBRANE ELECTRONICS | Non-Final OA | EMORY UNIVERSITY |
| 18792147 | TEMPERATURE MEASUREMENT DEVICE | Final Rejection | Murata Manufacturing Co., Ltd. |
| 18386895 | IMPLANTABLE MEDICAL SYSTEMS FOR CANCER TREATMENT WITH THERMAL MANAGEMENT FEATURES | Non-Final OA | Cardiac Pacemakers, Inc. |
| 19040095 | TREATMENT DEVICE WITH DAMPING FEATURE | Non-Final OA | OLYMPUS MEDICAL SYSTEMS CORP. |
| 19108326 | ACUTE HEALTH EVENT DETECTION DURING DRUG LOADING | Non-Final OA | Medtronic, Inc. |
| 17875231 | SURGICAL DEVICE SYSTEM | Final Rejection | ARTHREX, INC. |
| 19028934 | WEARABLE DEFIBRILLATOR SYSTEM FORWARDING PATIENT INFORMATION BASED ON RECIPIENT PROFILE AND/OR EVENT TYPE | Non-Final OA | West Affum Holdings DAC |
| 18619957 | COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING TUMOR TREATING FIELDS AND KILLER CELLS | Non-Final OA | Novocure GmbH |
| 18712491 | SYSTEMS AND METHODS FOR WIRELESS POWER RESONATORS WITH OPEN CORE | Non-Final OA | TC1 LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy